Net Margin - Shedir Pharma Srl Unipersonale (MIL:SHE) - Alpha Spread

Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 3.8 EUR
Market Cap: 43.4m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Net Margin
Shedir Pharma Srl Unipersonale

9.6%
Current
9%
Average
4.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.6%
=
Net Income
5.7m
/
Revenue
59.4m

Net Margin Across Competitors

Country IT
Market Cap 43.2m EUR
Net Margin
10%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 853.5B USD
Net Margin
19%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.5T DKK
Net Margin
35%
Country US
Market Cap 385.7B USD
Net Margin
44%
Country US
Market Cap 278.6B USD
Net Margin
22%
Country UK
Market Cap 240B USD
Net Margin
13%
Country CH
Market Cap 207.1B CHF
Net Margin
20%
Country CH
Market Cap 191.2B CHF
Net Margin
33%
Country US
Market Cap 166.8B USD
Net Margin
-5%

Profitability Report

View the profitability report to see the full profitability analysis for Shedir Pharma Srl Unipersonale.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.6%
=
Net Income
5.7m
/
Revenue
59.4m
What is the Net Margin of Shedir Pharma Srl Unipersonale?

Based on Shedir Pharma Srl Unipersonale's most recent financial statements, the company has Net Margin of 9.6%.